Expanding Therapeutic Options for Older Adults: Case-Based Updates in Breast and Lung Cancer.

@article{Magnuson2019ExpandingTO,
  title={Expanding Therapeutic Options for Older Adults: Case-Based Updates in Breast and Lung Cancer.},
  author={Allison Magnuson and Rawad Elias and Thuy T. Koll},
  journal={Journal of the American Geriatrics Society},
  year={2019},
  volume={67 5},
  pages={
          1012-1019
        }
}
Oncology care has become increasingly complex, with a dramatic increase in the number of available therapy options. Many newly developed medications have novel mechanisms of action and include targeted therapies and immunotherapy options. These agents typically have unique side effects that differ from more traditional cytotoxic chemotherapy regimens. Older adults represent the majority of patients with cancer and it is important for geriatricians and primary care providers for older adults to… CONTINUE READING

Tables and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 75 REFERENCES

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

  • The New England journal of medicine
  • 2015
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

  • The New England journal of medicine
  • 2015
VIEW 2 EXCERPTS
HIGHLY INFLUENTIAL